Crossmark

Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma

Crossref DOI link: https://doi.org/10.1186/s12885-020-07774-5

Published Online: 2021-02-22

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Yan

Zou, Dongmei

Yin, Jingjing

Zhang, Li

Zhang, Xiao

Wang, Wei

Zhang, Meifen

Zhou, Daobin

Zhang, Wei http://orcid.org/0000-0001-9489-5965
Funding

Funding for this research was provided by:

Chinese Academy of Medical Sciences (CAMS Innovation Fund of Medical Sciences(CIFMS) 2019-I2M-2-009)

Chinese Academy of Medical Sciences (CAMS Innovation Fund of Medical Sciences(CIFMS) 2016-12M-1-001)
License Information

Text and Data Mining valid from 2021-02-22

Version of Record valid from 2021-02-22
More Information

Article History

Received: 23 July 2020

Accepted: 26 December 2020

First Online: 22 February 2021

Ethics approval and consent to participate

: This retrospective study was approved by the Ethical Committee of Peking Union Medical College Hospital and all patients signed informed consent forms before sample collection.

: Not Applicable.

: None of the authors reported a conflict of interest in respect to this study.

Document is current

Any future updates will be listed below